1. Home
  2. BBU vs SUPN Comparison

BBU vs SUPN Comparison

Compare BBU & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brookfield Business Partners L.P. Limited Partnership Units

BBU

Brookfield Business Partners L.P. Limited Partnership Units

HOLD

Current Price

$31.46

Market Cap

3.1B

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$50.21

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBU
SUPN
Founded
2016
2005
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.8B
IPO Year
2015
2010

Fundamental Metrics

Financial Performance
Metric
BBU
SUPN
Price
$31.46
$50.21
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$39.40
$61.60
AVG Volume (30 Days)
43.8K
493.2K
Earning Date
05-01-2026
05-05-2026
Dividend Yield
0.79%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$392,755,000.00
Revenue This Year
N/A
$22.72
Revenue Next Year
N/A
$18.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.71
$29.16
52 Week High
$37.75
$59.68

Technical Indicators

Market Signals
Indicator
BBU
SUPN
Relative Strength Index (RSI) 44.87 47.87
Support Level $29.90 $47.43
Resistance Level $36.93 $52.14
Average True Range (ATR) 1.38 1.58
MACD 0.23 0.09
Stochastic Oscillator 46.92 60.32

Price Performance

Historical Comparison
BBU
SUPN

About BBU Brookfield Business Partners L.P. Limited Partnership Units

Brookfield Business Partners LP is a business services and industrials company. It focused on operating businesses that are either low-cost producers and benefit from high barriers to entry. The company's operating segment includes Business services; Infrastructure services; Industrials and Corporate and other. It generates maximum revenue from the Business Services segment. Geographically operates in USA, Europe, Australia, Brazil, Canada, UK, Mexico and Other, majority of revenue is from UK.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: